JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia
NCT00860522
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
JVRS-100
DRUG:
JVRS-100
Sponsor
Milton S. Hershey Medical Center